Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05510661 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Export in Primary Percutaneous Coronary Intervention

Study acronym: EPISOO
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of May 31, 2025 to Sep 24, 2025
    • Site details revised
    v7
  2. Notable Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Primary completion date: Dec 1, 2024 to May 31, 2025
    • Study sites: 0 to 1
    • Study completion date: Jan 1, 2025 to May 31, 2026
    • Start date changed from estimate of Dec 1, 2023 to Jan 15, 2024
  3. Notable Start date: Sep 15, 2023 to Dec 1, 2023
    • Primary completion date: Sep 15, 2024 to Dec 1, 2024
    • Study completion date: Oct 31, 2024 to Jan 1, 2025
    v5
  4. Notable Start date: Aug 15, 2023 to Sep 15, 2023
    • Primary completion date: Aug 15, 2024 to Sep 15, 2024
    v4
  5. Notable Primary completion date: Feb 15, 2023 to Aug 15, 2024
    • Start date: Oct 15, 2022 to Aug 15, 2023
    • Study completion date: Mar 31, 2023 to Oct 31, 2024
    v3
  6. Notable Start date: Sep 1, 2022 to Oct 15, 2022v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.
Trial Details
NCT Number NCT05510661
Lead Sponsor National Institute of Cardiovascular Diseases, Pakistan
Collaborators: Medtronic
Conditions
(from sponsor)
ST-segment Elevation Myocardial Infarction (STEMI), Total Occlusion of Coronary Artery, Primary Percutaneous Coronary Intervention
Related terms ST Elevation Myocardial Infarction
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov